Dr Joanna Birch

  • UKRI Future Leaders Fellow (Therapeutic Science Research)

email: Joanna.Birch@glasgow.ac.uk

RI Cancer Sciences, Wolfson Wohl building, Garscube estate, Switchback Road, G61 1QH

Publications

List by: Type | Date

Jump to: 2021 | 2019 | 2018 | 2016 | 2010
Number of items: 7.

2021

Al-mubarak, H., Vallatos, A., Gallagher, L., Birch, J., Chalmers, A.J. and Holmes, W.M. (2021) Evaluating potential of multi-parametric MRI using co-registered histology: Application to a mouse model of glioblastoma. Magnetic resonance imaging, 85, pp. 121-127. (doi: 10.1016/j.mri.2021.10.030) (PMID:34687852)

2019

Al-Mubarak, H., Vallatos, A., Gallagher, L., Birch, J., Gilmour, L., Foster, J., Chalmers, A.J. and Holmes, W.M. (2019) Stacked in-plane histology for quantitative validation of non-invasive imaging biomarkers: application to an infiltrative brain tumour model. Journal of Neuroscience Methods, 326, 108372. (doi: 10.1016/j.jneumeth.2019.108372) (PMID:31348965)

Vallatos, A., Al-Mubarak, H.F.I., Birch, J.L., Gallagher, L., Mullin, J.M., Gilmour, L., Holmes, W.M. and Chalmers, A.J. (2019) Quantitative histopathologic assessment of perfusion MRI as a marker of glioblastoma cell infiltration in and beyond the peritumoral edema region. Journal of Magnetic Resonance Imaging, 50(2), pp. 529-540. (doi: 10.1002/jmri.26580) (PMID:30569620)

2018

Birch, J. L. et al. (2018) A novel small-molecule inhibitor of MRCK prevents radiation-driven invasion in glioblastoma. Cancer Research, 78(22), pp. 6509-6522. (doi: 10.1158/0008-5472.CAN-18-1697) (PMID:30279244)

2016

Birch, J. et al. (2016) The initiator methionine tRNA drives cell migration and invasion leading to increased metastatic potential in melanoma. Biology Open, 5(10), pp. 1371-1379. (doi: 10.1242/bio.019075) (PMID:27543055) (PMCID:PMC5087684)

Clarke, C. J. et al. (2016) The initiator methionine tRNA drives secretion of type II collagen from stromal fibroblasts to promote tumor growth and angiogenesis. Current Biology, 26(6), pp. 755-765. (doi: 10.1016/j.cub.2016.01.045) (PMID:26948875) (PMCID:PMC4819511)

2010

Barski, A., Chepelev, I., Liko, D., Cuddapah, S., Fleming, A., Birch, J., Cui, K., White, R.J. and Zhao, K. (2010) Pol II and its associated epigenetic marks are present at Pol III–transcribed noncoding RNA genes. Nature Structural and Molecular Biology, 17(5), pp. 629-634. (doi: 10.1038/nsmb.1806)

This list was generated on Wed Nov 30 08:18:40 2022 GMT.
Jump to: Articles
Number of items: 7.

Articles

Al-mubarak, H., Vallatos, A., Gallagher, L., Birch, J., Chalmers, A.J. and Holmes, W.M. (2021) Evaluating potential of multi-parametric MRI using co-registered histology: Application to a mouse model of glioblastoma. Magnetic resonance imaging, 85, pp. 121-127. (doi: 10.1016/j.mri.2021.10.030) (PMID:34687852)

Al-Mubarak, H., Vallatos, A., Gallagher, L., Birch, J., Gilmour, L., Foster, J., Chalmers, A.J. and Holmes, W.M. (2019) Stacked in-plane histology for quantitative validation of non-invasive imaging biomarkers: application to an infiltrative brain tumour model. Journal of Neuroscience Methods, 326, 108372. (doi: 10.1016/j.jneumeth.2019.108372) (PMID:31348965)

Vallatos, A., Al-Mubarak, H.F.I., Birch, J.L., Gallagher, L., Mullin, J.M., Gilmour, L., Holmes, W.M. and Chalmers, A.J. (2019) Quantitative histopathologic assessment of perfusion MRI as a marker of glioblastoma cell infiltration in and beyond the peritumoral edema region. Journal of Magnetic Resonance Imaging, 50(2), pp. 529-540. (doi: 10.1002/jmri.26580) (PMID:30569620)

Birch, J. L. et al. (2018) A novel small-molecule inhibitor of MRCK prevents radiation-driven invasion in glioblastoma. Cancer Research, 78(22), pp. 6509-6522. (doi: 10.1158/0008-5472.CAN-18-1697) (PMID:30279244)

Birch, J. et al. (2016) The initiator methionine tRNA drives cell migration and invasion leading to increased metastatic potential in melanoma. Biology Open, 5(10), pp. 1371-1379. (doi: 10.1242/bio.019075) (PMID:27543055) (PMCID:PMC5087684)

Clarke, C. J. et al. (2016) The initiator methionine tRNA drives secretion of type II collagen from stromal fibroblasts to promote tumor growth and angiogenesis. Current Biology, 26(6), pp. 755-765. (doi: 10.1016/j.cub.2016.01.045) (PMID:26948875) (PMCID:PMC4819511)

Barski, A., Chepelev, I., Liko, D., Cuddapah, S., Fleming, A., Birch, J., Cui, K., White, R.J. and Zhao, K. (2010) Pol II and its associated epigenetic marks are present at Pol III–transcribed noncoding RNA genes. Nature Structural and Molecular Biology, 17(5), pp. 629-634. (doi: 10.1038/nsmb.1806)

This list was generated on Wed Nov 30 08:18:40 2022 GMT.

Grants

Grants and Awards listed are those received whilst working with the University of Glasgow.

  • IL6/JAK/STAT3 pathway in colorectal cancer
    Office of the Chief Scientific Adviser
    2023 - 2025
     
  • An investigation into the therapeutic potential of combining radiotherapy and IKK inhibition for rectal cancer patients
    Office of the Chief Scientific Adviser
    2023 - 2025
     
  • Investigating pro-invasive gene signatures arising from acute irradiation of pancreatic cancer cells
    Cancer Research UK
    2022 - 2022
     
  • Investigating BH3 mimetics as radiosensitising agents in glioblastoma and pancreatic ductal adenocarcinoma
    Cancer Research UK
    2022 - 2022
     
  • Combining Radiation with JAK inhibitors as a novel therapeutic strategy
    Cancer Research UK
    2022 - 2022
     
  • Developing better models of the blood-tumour barrier to enhance drug development for glioblastoma
    Office of the Chief Scientific Adviser
    2021 - 2023
     
  • Targeting radiation driven invasion and metastasis in cancers of unmet need
    Medical Research Council
    2021 - 2024
     
  • Probing the ability of a novel MRCK inhibitor, BDP-0009066, to prolong survival in a pre-clinical model of Glioblastoma
    Cancer Research Technology
    2018 - 2019
     
  • ESTABLISHING INTRAVITAL BRAIN IMAGING IN PRE-CLINICAL MOUSE MODELS
    European Society for Radiation Oncology
    2014 - 2014
     
  • Development Award: Measurement of Small Molecule Pharmacokinetics in invasive Regions of Glioblastoma
    Cancer Research UK
    2014 - 2016